Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on the development and commercialization of therapies for the localized treatment of patients with chronic rhinosinusitis (CRS). The Company has two investigatio... Read more
Yahoo
MarketWatch
SeekingAlpha
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.